TrademarkOpen
Search / United States / 88761298

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

VIM

Registered
Used for: human amniotic membrane allograft

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 20 Jan 2020
    Application filed
    New Application Entered
  2. 6 Apr 2020
    Assigned to an examining attorney
    Assigned To Examiner
  3. 7 Apr 2020
    Approved for publication
    Approved For Pub - Principal Register
  4. 19 May 2020
    Published for opposition
    Published For Opposition
  5. 14 Jul 2020
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 15 Dec 2020
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  7. 25 Jun 2021
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  8. 15 Dec 2021
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
  9. 13 Dec 2022
    Statement of use filed
    Teas Statement Of Use Received
  10. 18 Jan 2023
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  11. 19 Jan 2023
    Statement of use accepted
    Notice Of Acceptance Of Statement Of Use E-Mailed
  12. 21 Feb 2023
    Registered on the Principal Register
    Registered-Principal Register
All 36 events
2025-11-26Assignment Of Ownership Not Updated Automatically
2025-10-27Assignment Of Ownership Not Updated Automatically
2025-10-27Assignment Of Ownership Not Updated Automatically
2025-10-27Assignment Of Ownership Not Updated Automatically
2023-02-21Registered-Principal Register
2023-02-21Notice Of Registration Confirmation Emailed
2023-01-19Notice Of Acceptance Of Statement Of Use E-Mailed
2023-01-18Allowed Principal Register - Sou Accepted
2023-01-17Statement Of Use Processing Complete
2023-01-12Case Assigned To Intent To Use Paralegal
2022-12-13Teas Statement Of Use Received
2022-12-13Use Amendment Filed
2022-07-16Notice Of Approval Of Extension Request E-Mailed
2022-07-14Sou Teas Extension Received
2022-07-14Sou Extension 4 Filed
2022-07-14Sou Extension 4 Granted
2021-12-17Notice Of Approval Of Extension Request E-Mailed
2021-12-15Sou Teas Extension Received
2021-12-15Sou Extension 3 Filed
2021-12-15Sou Extension 3 Granted
2021-06-29Notice Of Approval Of Extension Request E-Mailed
2021-06-25Sou Teas Extension Received
2021-06-25Sou Extension 2 Filed
2021-06-25Sou Extension 2 Granted
2020-12-17Notice Of Approval Of Extension Request E-Mailed
2020-12-15Sou Teas Extension Received
2020-12-15Sou Extension 1 Filed
2020-12-15Sou Extension 1 Granted
2020-07-14Noa Mailed - Sou Required From Applicant
2020-05-19Published For Opposition
2020-05-19Official Gazette Publication Confirmation E-Mailed
2020-04-29Notification Of Notice Of Publication E-Mailed
2020-04-07Approved For Pub - Principal Register
2020-04-06Assigned To Examiner
2020-01-22New Application Office Supplied Data Entered
2020-01-20New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

human amniotic membrane allograft

First use anywhere 12 May 2022 · First use in commerce 12 May 2022

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 13 Jan 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.